SecBot SecBot
8-K ·Filed Mar 12, 2026

DNTH

Dianthus Therapeutics, Inc. /DE/
NEUTRAL
Impact 3/10
Horizondays Processed8mo ago SEC0001193125-26-103053
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight • Neutral

Monitor for public disclosure or press release from Dianthus Therapeutics regarding the nature of the agreement. Absence of financial details limits immediate trading implications.

DirectionNeutral
Confidencelow
Horizondays

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$80.32
T+0 close · Mar 12, 2026 · via day close
Latest settled
+0.24%
T+60 · $80.51
Vs SPY
−10.46%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Mar 12 $80.32entry
  2. T+1 · 8mo ago −3.06%α −2.47% · $77.86
  3. T+5 · 8mo ago −0.40%α +0.58% · $80.00
  4. T+20 · 7mo ago +11.77%α +9.79% · $89.77
  5. T+60 · 5mo ago +0.24%α −10.46% · $80.51
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Analysis based on filing metadata only, document content was unavailable. The filing is an 8-K with Items 1.01 (Entry into Material Definitive Agreement) and 9.01 (Financial Statements and Exhibits), suggesting Dianthus Therapeutics may have entered a significant agreement, but no details are accessible to confirm nature or terms.

Key Facts

  • Filing is Form 8-K with Items 1.01 and 9.01 reported.
  • Item 1.01 indicates a material definitive agreement may have been entered into.
  • Item 9.01 suggests financial statements or exhibits were filed, possibly related to the agreement.
  • No document content available to verify agreement type, parties, or financial terms.

Financial Impact

Not specified

Risk Factors

  • Material agreement could involve dilution, contingent payments, or strategic shift not currently quantifiable.
  • Lack of accessible filing content increases information asymmetry risk.

Market Snapshot

Exchange
Nasdaq

Investment Themes

Documents Analyzed

Report based on filing metadata.

Track record

23 reports on DNTH

Performance horizon

7 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +41.40% at T+60 after the Jun 11, 2026 report. 8 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $89.76 Now $89.55 −0.23% settles Nov 17
  2. Nov 9, 20267d ago 144 Neutral 3/10 Entry $88.81 to $89.30 Now $89.55 +0.83% ▲ +0.55% −0.77% vs SPY
  3. Nov 4, 202612d ago 8-K Neutral 4/10 No price data
  4. Nov 4, 202612d ago Press Release Neutral 4/10 Entry $83.01 to $86.03 Now $89.55 +7.88% ▲ +3.64% +3.33% vs SPY
  5. Oct 30, 202617d ago Institutional Cluster Neutral 3/10 Entry $82.38 to $82.25 Now $89.55 +8.70% ▼ −0.16% +0.32% vs SPY
  6. Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $82.38 to $82.25 Now $89.55 +8.70% ▼ −0.16% +0.32% vs SPY
  7. Oct 12, 20265w ago Institutional Cluster Mixed 3/10 Entry $81.57 to $77.58 Now $89.55 +9.78% ▼ −4.89% −4.88% vs SPY
  8. Aug 11, 202613w ago Insider Cluster Neutral 4/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
  9. Aug 11, 202613w ago Insider Cluster Neutral 3/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
  10. Aug 11, 202613w ago Insider Cluster Neutral 3/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
Showing 10 of 23

US Market Status

Market Closed · Opens Wed (10h 5m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Mar 12, 2026